We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The lab of one University of Illinois researcher is receiving a hefty grant, which will be used towards cancer research. On ...

FDA's approval of Astellas' therapy for gastric cancer, and CVS Health's leadership shuffle as Karen Lynch steps down amid ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

Researchers are developing an mRNA vaccine to protect against Clostridioides difficile bacteria, known for causing severe ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

(HealthDay News) — COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as ...

There were no safety concerns identified among older adults following revaccination with the investigational respiratory syncytial virus vaccine mRNA-1345, and immune responses elicited by ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

The case of avian influenza A (H5) confirmed by the Centers for Disease Control and Prevention in Missouri, USA, on Sept 6, 2024,1 has reignited concerns about the risk of human contagion and the need ...